© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
September 17, 2013
Can You Read These Rxs?
September 16, 2013
Ovarian Cancer Watch
Prostate Cancer Watch
According to the results of a large cohort study, men with high blood concentrations of omega-3 fatty acids may be at an increased risk for developing prostate cancer.
Methamphetamine abuse costs many lives and dollars every year.
September 13, 2013
Technology Product News
Thousands of criminal Internet pharmacies dispense millions of dosage units of pharmaceuticals.
When a pharmaceutical wholesaler notifies a community pharmacy that it will no longer distribute controlled substances, the pharmacy seeks a temporary injunction.
Special Section: Immunizations & Vaccinations
There's a reason most school systems require proof of vaccination before students begin in the fall.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
Generic Times Product NEWS
September 12, 2013
Pharmacist to Pharmacist
UCERIS is indicated for inducing remission in patients with active, mild to moderate ulcerative colitis.
All too often, mix-ups between metric and nonmetric units cause serious medication errors.
Keeping up with advances in oncology is a welcome challenge.
Homeopathy is becoming increasingly complementary to allopathic medicine.
Brown Bag Consult
Lives can be saved by encouraging screening for colorectal cancer in eligible patients.
September 11, 2013
Oral antineoplastics have advantages, but patient adherence is a concern.
Rx Product News Profile
Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.
Why are computerized drug-drug interaction alerts usually ignored?
September 10, 2013
Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.
The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis
OTC Case Studies
OTC Product News
Rx Product News
September 09, 2013
Federal rules are very specific.